5-Hydroxytryptamine–Induced Potentiation of Endothelin-1– and Norepinephrine-Induced Contraction Is Mitogen-Activated Protein Kinase Pathway Dependent
- 1 January 2000
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 35 (1) , 244-248
- https://doi.org/10.1161/01.hyp.35.1.244
Abstract
Abstract —5-Hydroxytryptamine (5-HT)–induced arterial contraction depends on activation of the tyrosine kinase–dependent extracellular signal-regulated mitogen-activated protein kinase (Erk MAPK) pathway. The importance of 5-HT in the control of peripheral resistance has been questioned because circulating free levels of 5-HT are low (in the nanomolar range). We tested the hypothesis that physiologically relevant concentrations of 5-HT potentiate arterial contraction in response to agonists proved to have importance in blood pressure maintenance (norepinephrine [NE] and endothelin-1 [ET-1]) in a tyrosine kinase– and an Erk MAPK–dependent manner. Strips of endothelium-denuded rat tail artery were used for the measurement of isometric force. The general tyrosine kinase inhibitor genistein (5 μmol/L) and the inhibitor of MAPK/Erk kinase activation PD098059 (10 μmol/L) shifted concentration-response curves to 5-HT (1×10 −9 to 3×10 −4 mol/L) rightward but did not shift concentration-response curves to NE or ET-1. In separate experiments, 5-HT (10 nmol/L) potentiated contraction in response to NE (20 nmol/L) by ≈200% to 300% and to ET-1 (0.3 and 1 nmol/L) by 640% and 180%, respectively. Genistein and PD098059 significantly (66% to 100%) reduced 5-HT–induced potentiation of both NE (20 nmol/L)- and ET-1 (0.3 and 1 nmol/L)–induced contraction. Thus, these data support the ability of low physiological concentrations of 5-HT to amplify arterial responses to hormones with bona fide effects on blood pressure in the novel manner of depending on a tyrosine kinase/Erk MAPK pathway. Although these findings were generated in large arteries, we speculate that they may be applicable to vascular functioning in the deoxycorticosterone acetate salt model of hypertension in which all 3 hormones, 5-HT, NE, and ET-1, have been implicated as causal factors.Keywords
This publication has 24 references indexed in Scilit:
- Activation of the Mitogen‐activated Protein Kinase Pathwayviathe 5‐HT2AReceptoraAnnals of the New York Academy of Sciences, 1998
- Role of Tyrosine Kinases in Norepinephrine-Induced Contraction of Vascular Smooth MuscleJournal of Cardiovascular Pharmacology, 1995
- Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentanCanadian Journal of Physiology and Pharmacology, 1995
- Vascular receptors for 5-hydroxytryptamine: Distribution, function and classificationPharmacology & Therapeutics, 1994
- Inhibition of EGF-Induced Vasoconstriction in Isolated Rabbit Aortic Rings with the Tyrosine Kinase Inhibitor RG50864Biochemical and Biophysical Research Communications, 1993
- Identification of mitogen‐activated protein kinase phosphorylation sequences in mammalian h‐CaldesmonFEBS Letters, 1993
- Tyrosine Kinase Inhibitors Suppress Agonist-Induced Contraction in Smooth MuscleBiochemical and Biophysical Research Communications, 1993
- Endothelin-1 stimulates tyrosine phosphorylation and the activities of two mitogen-activated protein kinases in cultured vascular smooth muscle cellsJournal Of Hypertension, 1992
- AMPLIFICATION BY SEROTONIN OF RESPONSES TO OTHER VASOCONSTRICTOR AGENTS IN THE RAT TAIL ARTERYClinical and Experimental Pharmacology and Physiology, 1989
- Vascular serotonin receptors and blood pressure regulationDrug Development Research, 1984